Pharmaceutical

Subscribe

In a press release, Novartis announced that it will add 300 new jobs and invest $600 million over the next five years to expand its global research headquarters campus in

PRNewswire reports, Asia''s premier biotechnology company, Biocon, and Pfizer Inc. announced they have entered into a strategic global agreement for the worldwide commercialization of Biocon''s biosimilar versions of Insulin and

The BBC reports, French pharmaceutical giant Sanofi-Aventis has announced it will shed 1,700 jobs from its U.S. workforce. The move is part of a restructuring process that will allow

Sanofi-Aventis said that it has launched a hostile $18.5 billion offer for Genzyme Corp. after the U.S. company previously rejected an approach at the same price, reports MarketWatch. The offer

Crown Holdings Inc. will build three new beverage can plants in China in order to keep up with increased demand, the packaging products supplier said, reports the Associated Press. The

The Associated Press Reports, Hospira has received approval to sell a generic version of the biotech drug Neupogen in Australia. Hospira said its drug, called Nivestim, was approved to prevent

The Associated Press reports, Genzyme Corp. said its drug Synvisc, which treats osteoarthritis of the knee, has been approved in Japan. Genzyme said it received marketing approval from the Ministry

U.S. biotechnology company Genzyme has agreed to sell its genetic testing business to Laboratory Corp of America Holdings for $925 million in cash, reports Reuters. Genzyme said its plan

The board of directors at U.S. biotechnology firm Genzyme has unanimously rejected an 18.5-billion-dollar takeover offer from French pharmaceutical giant Sanofi-Aventis, reports the Associated Foreign Press. A letter to Sanofi

According to the Associated Press, Swiss pharmaceutical company Roche Group is buying California-based medical scanning company BioImagene Inc. for $100 million. Roche made the announcement and says it expects to